160 related articles for article (PubMed ID: 21134256)
1. PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects.
Kleczkowska P; Kosson P; Ballet S; Van den Eynde I; Tsuda Y; Tourwé D; Lipkowski AW
Mol Pain; 2010 Dec; 6():86. PubMed ID: 21134256
[TBL] [Abstract][Full Text] [Related]
2. Identification of Dmt-D-Lys-Phe-Phe-OH as a highly antinociceptive tetrapeptide metabolite of the opioid-neurotensin hybrid peptide PK20.
Kleczkowska P; Bojnik E; Leśniak A; Kosson P; Van den Eynde I; Ballet S; Benyhe S; Tourwé D; Lipkowski AW
Pharmacol Rep; 2013; 65(4):836-46. PubMed ID: 24145077
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effect induced by a combination of opioid and neurotensin moieties vs. their hybrid peptide [Ile(9)]PK20 in an acute pain treatment in rodents.
Kleczkowska P; Hermans E; Kosson P; Kowalczyk A; Lesniak A; Pawlik K; Bojnik E; Benyhe S; Nowicka B; Bujalska-Zadrozny M; Misicka A; Lipkowski AW
Brain Res; 2016 Oct; 1648(Pt A):172-180. PubMed ID: 27473894
[TBL] [Abstract][Full Text] [Related]
4. Role of neurotensin and opioid receptors in the cardiorespiratory effects of [Ile⁹]PK20, a novel antinociceptive chimeric peptide.
Kaczyńska K; Szereda-Przestaszewska M; Kleczkowska P; Lipkowski AW
Eur J Pharm Sci; 2014 Oct; 63():8-13. PubMed ID: 25008116
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities.
Wang ZL; Pan JX; Song JJ; Tang HH; Yu HP; Li XH; Li N; Zhang T; Zhang R; Zhang MN; Xu B; Fang Q; Wang R
J Med Chem; 2016 Nov; 59(22):10198-10208. PubMed ID: 27798836
[TBL] [Abstract][Full Text] [Related]
6. Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog.
Tétreault P; Besserer-Offroy É; Brouillette RL; René A; Murza A; Fanelli R; Kirby K; Parent AJ; Dubuc I; Beaudet N; Côté J; Longpré JM; Martinez J; Cavelier F; Sarret P
Eur J Pharmacol; 2020 Sep; 882():173174. PubMed ID: 32534076
[TBL] [Abstract][Full Text] [Related]
7. Contribution of opioid and neurotensin receptors in the anti-inflammatory activity of PK20 hybrid compound in murine airways.
Russjan E; Zając D; Sulejczak D; Kleczkowska P; Kaczyńska K
Clin Exp Pharmacol Physiol; 2021 Aug; 48(8):1162-1170. PubMed ID: 33851456
[TBL] [Abstract][Full Text] [Related]
8. BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice.
Li N; Han ZL; Wang ZL; Xing YH; Sun YL; Li XH; Song JJ; Zhang T; Zhang R; Zhang MN; Xu B; Fang Q; Wang R
Br J Pharmacol; 2016 Jun; 173(11):1864-80. PubMed ID: 27018797
[TBL] [Abstract][Full Text] [Related]
9. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
Tershner SA; Helmstetter FJ
Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
[TBL] [Abstract][Full Text] [Related]
10. Effects of the Hybridization of Opioid and Neurotensin Pharmacophores on Cell Survival in Rat Organotypic Hippocampal Slice Cultures.
Kleczkowska P; Kawalec M; Bujalska-Zadrozny M; Filip M; Zablocka B; Lipkowski AW
Neurotox Res; 2015 Nov; 28(4):352-60. PubMed ID: 26286504
[TBL] [Abstract][Full Text] [Related]
11. Spinal DN-9, a Peptidic Multifunctional Opioid/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects.
Wang Z; Xu B; Jiang C; Zhang T; Zhang M; Li N; Zhang Q; Xu K; Chen D; Xiao J; Fang Q
J Pain; 2020; 21(3-4):477-493. PubMed ID: 31521796
[TBL] [Abstract][Full Text] [Related]
12. Comparative Study of Chemical Stability of a PK20 Opioid-Neurotensin Hybrid Peptide and Its Analogue [Ile
Żyżyńska-Granica B; Mollica A; Stefanucci A; Granica S; Kleczkowska P
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142749
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation--a review.
Kleczkowska P; Lipkowski AW
Eur J Pharmacol; 2013 Sep; 716(1-3):54-60. PubMed ID: 23500196
[TBL] [Abstract][Full Text] [Related]
14. Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.
Chartier M; Desgagné M; Sousbie M; Côté J; Longpré JM; Marsault E; Sarret P
J Med Chem; 2021 Feb; 64(4):2110-2124. PubMed ID: 33538583
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides.
Elmagbari NO; Egleton RD; Palian MM; Lowery JJ; Schmid WR; Davis P; Navratilova E; Dhanasekaran M; Keyari CM; Yamamura HI; Porreca F; Hruby VJ; Polt R; Bilsky EJ
J Pharmacol Exp Ther; 2004 Oct; 311(1):290-7. PubMed ID: 15166257
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and respiratory activity of PK20, opioid and neurotensin hybrid peptide in anesthetized and awake rats.
Kaczyńska K; Wojciechowski P; Jampolska M; Lipkowski AW; Kleczkowska P
Eur J Pharmacol; 2017 Feb; 797():20-25. PubMed ID: 28089918
[TBL] [Abstract][Full Text] [Related]
17. The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio.
Eiselt E; Côté J; Longpré JM; Blais V; Sarret P; Gendron L
Eur J Pharmacol; 2019 Apr; 848():80-87. PubMed ID: 30707956
[TBL] [Abstract][Full Text] [Related]
18. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
19. NT69L, a novel analgesic, shows synergy with morphine.
Boules M; Shaw A; Liang Y; Barbut D; Richelson E
Brain Res; 2009 Oct; 1294():22-8. PubMed ID: 19651107
[TBL] [Abstract][Full Text] [Related]
20. Peripheral antinociceptive efficacy and potency of a novel opioid compound 14-O-MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of inflammatory pain.
Khalefa BI; Mousa SA; Shaqura M; Lackó E; Hosztafi S; Riba P; Schäfer M; Ferdinandy P; Fürst S; Al-Khrasani M
Eur J Pharmacol; 2013 Aug; 713(1-3):54-7. PubMed ID: 23665110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
